iBio
IBIO
#10074
Rank
NZ$46.71 M
Marketcap
NZ$2.08
Share price
-6.25%
Change (1 day)
-52.82%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$3.86

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$3.95. In 2024 the company made an earnings per share (EPS) of NZ-$11.25 an increase over its 2023 EPS that were of NZ-$183.81.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$3.86-65.69%
2024NZ-$11.25-93.88%
2023NZ-$183.81-8.14%
2022NZ-$200.1092.67%
2021NZ-$103.86-80.33%
2020NZ-$527.95-35.11%
2019NZ-$813.57-38.96%
2018NZ-$1,333-6.1%
2017NZ-$1,41936.67%
2016NZ-$1,03933.33%
2015NZ-$778.9550%
2014NZ-$519.30-53.85%
2013NZ-$1,125-7.14%
2012NZ-$1,212-64.1%
2011NZ-$3,37577.27%
2010NZ-$1,904144.44%
2009NZ-$778.9512.93%
2008NZ-$689.7812.2%
2007NZ-$614.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.90-77.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.44-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.07-557.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$7.32 85.53%๐Ÿ‡บ๐Ÿ‡ธ USA